Categories: DNANews

Neogen® Launches New MDA2 Quantitative Salmonella Molecular Detection Assay

LANSING, Mich., Jan. 16, 2025 /PRNewswire/ — Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today the launch of the new Neogen Molecular Detection Assay 2 – Quantitative Salmonella (MDA2QSAL96).

The Neogen MDA2QSAL96 kit integrates qualitative pathogen testing solutions and Quantitative Rapid Enrichment Dehydrated (QRED) media designed to enable controlled growth rates for quantitation, allowing poultry producers to verify the effectiveness of their interventions. This quantitative method delivers excellent consistency and sensitivity on poultry rinses and ground poultry meat, with an easy-to-use workflow that saves time and resources.

“We are pleased to bring this advanced technology to our customers, helping them to enhance their food safety program and address a challenging need in the poultry industry,” said John Adent, Neogen’s President and CEO. “This assay overcomes certain limitations of existing solutions, with improved sensitivity and accuracy, and an easy-to-use workflow.”

The product joins several other next-generation assays, including Salmonella, Salmonella Enteriditis and Typhimurium, E. coli O157 (including H7), Listeria spp., Listeria monocytogenes, Campylobacter, STEC gene screen (stx and eae), STEC gene screen (stx), and Cronobacter, as part of the Neogen Molecular Detection System pathogen testing platform.

The award-winning Neogen Molecular Detection System platform is used by food processors, universities, governments, and contract testing laboratories in more than 40 countries. It is powered by a combination of advanced technologies—isothermal DNA amplification and bioluminescence detection—to provide a pathogen testing solution that is fast, accurate, easy to use, and affordable.

The U.S. Department of Agriculture Food Safety and Inspection Service (USDA FSIS) named the Neogen Molecular Detection System as the primary method for the detection of Salmonella, Listeria monocytogenes, and Listeria spp., as well as including the Neogen Molecular Detection Assay 2 – Salmonella Enteritidis/Salmonella Typhimurium.

Individuals interested in this new technology may contact their local Neogen Food Safety representative or visit info.neogen.com/quant-salmonella to learn more.

About Neogen

Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.

Contact
PR@Neogen.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/neogen-launches-new-mda2-quantitative-salmonella-molecular-detection-assay-302352872.html

SOURCE Neogen Corporation

Staff

Recent Posts

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

21 hours ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

21 hours ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

21 hours ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

21 hours ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…

21 hours ago

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading…

21 hours ago